Paid Clinical Trials West Virginia
Discover 372 paid clinical trials in West Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Mezigdomide & CarfilzomibA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05552976
Conditions
Relapsed or Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Mezigdomide
Carfilzomib
Dexamethasone
PembrolizumabLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT03486873
Conditions
Solid Tumors
Hematologic Malignancies
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Standard of Care (SOC)
Lenvatinib
Olaparib
MK-4280
AvacopanA Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Sponsor:
Amgen
Location:
Code:
NCT06072482
Conditions
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Avacopan
Placebo
Standard of Care
UpadacitinibA Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
Sponsor:
AbbVie
Location:
Code:
NCT05889182
Conditions
Hidradenitis Suppurativa
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Upadacitinib
Placebo
ProTractX3™ DCBPaclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Sponsor:
GIE Medical
Location:
Code:
NCT05561127
Conditions
Bowel; Stricture
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
GIE Medical ProTractX3 TTS DCB
Control
ColonoscopyFive or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Sponsor:
NRG Oncology
Location:
Code:
NCT05080673
Conditions
Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum
Eligibility Criteria
Sex: All
Age: 50 - 70
Healthy Volunteers: Not accepted
Interventions
5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy
Amivantamab-SubcutaneousTargeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT06116682
Conditions
Lung Non-Small Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Amivantamab
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
MILDMILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Sponsor:
Vertos Medical, Inc.
Location:
Code:
NCT03072927
Conditions
Lumbar Spinal Stenosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MILD
Interspinous Process Decompression
MagicTouchMagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Sponsor:
Concept Medical Inc.
Location:
Code:
NCT05908331
Conditions
In-Stent Restenosis
Cardiovascular Diseases
Coronary Artery Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Sirolimus Drug Coated Balloon
Plan balloon Angioplasty (POBA)
TulisokibartA Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06430801
Conditions
Crohn's Disease
Eligibility Criteria
Sex: All
Age: 16 - 70+
Healthy Volunteers: Not accepted
Interventions
IV Tulisokibart
SC Tulisokibart
IV Placebo
SC Placebo